InvestorsHub Logo
Followers 55
Posts 13532
Boards Moderated 0
Alias Born 10/12/2006

Re: None

Friday, 10/05/2018 9:37:09 AM

Friday, October 05, 2018 9:37:09 AM

Post# of 3985
Protalix BioTherapeutics Presents Positive Preliminary Data from the BRIDGE Study of pegunigalsidase alfa for the Treatment of Fabry Disease at the 1st Canadian Symposium on Lysosomal Diseases 2018

https://www.benzinga.com/pressreleases/18/10/g12463515/protalix-biotherapeutics-presents-positive-preliminary-data-from-the-b
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News